Aktuellt
SENASTE
Redeye endorses that CLS has received an order worth SEK5.5m from ClearPoint Neuro. CLS received FDA clearance for its MR-guided laser ablation system in neurosurgery a few weeks ago, and the order is a consequence of the initiated rollout in the US. We will provide an update in connection with the Q3 report, where we review the case and our forecasts.
LÄS MER
